Mechanisms of Increased Ambulatory Blood Pressure in Patients With Intradialytic Hypertension
Status:
Completed
Trial end date:
2018-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is 1) to determine what physiologic factors (extracellular fluid
overload or vasoconstriction) contribute more to increased blood pressure levels between
dialysis treatments in hemodialysis patients whose blood pressure increases and decreases
during hemodialysis and 2) to determine whether carvedilol provides better control of blood
pressure between dialysis treatments than prazosin in patients whose blood pressure increases
during dialysis.
Details
Lead Sponsor:
University of Texas Southwestern Medical Center
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)